Evolution of the Average Target: XP Inc.

Evolution of the Average Target - XP Inc.

Evolution of the Target Price: XP Inc.

Evolution of the Target Price - XP Inc.

Changes in Analyst Recommendations: XP Inc.

a4ea07.xdv_SR9zdn8dz-h620Dqq56vLnVqEpmhpFSaMRCSeF8._ZHIGmoyOT4ug98Z7HGLmOfdTDkdYdSXyRjAdlXrTRWN6LERVjs-Kl--qQ~5a6005884498dcf62b5eef0c64d1f5b6
10-08 UBS Adjusts Price Target on XP to $37 From $25, Keeps Buy Rating MT
10-06 XP Shares Rise After Itau BBA Upgrade MT
10-06 Itau BBA Upgrades XP to Outperform From Market Perform, Adjusts Price Target to $27 From $19 MT
08-31 Itau BBA Upgrades XP to Outperform From Market Perform, Adjusts PT to $22 From $19 MT
04-02 UBS Adjusts Price Target on XP to $28 From $25, Maintains Buy Rating MT
01-20 Jefferies Initiates XP at Buy With $22 Price Target MT
12-16 UBS Adjusts XP Price Target to $25 From $23, Maintains Buy Rating MT
25-10-16 UBS Adjusts Price Target on XP to $23 From $24, Maintains Buy Rating MT
25-06-23 XP Shares Drop After Downgrade From Itau BBA MT
25-06-23 Itau BBA Downgrades XP to Market Perform From Outperform, Adjusts Price Target to $21 From $20 MT
25-06-10 UBS Adjusts XP Price Target to $24 From $17, Maintains Buy Rating MT
25-06-04 Goldman Sachs Upgrades XP to Buy From Neutral, $23 Price Target MT
25-05-13 XP Shares Rise After Morgan Stanley Upgrades to Overweight From Equalweight MT
25-05-13 Morgan Stanley Upgrades XP to Overweight From Equalweight, Adjusts Price Target to $24 From $18 MT
25-04-07 UBS Adjusts Price Target on XP to $17 From $16, Keeps Buy Rating MT
25-03-18 Itau BBA Initiates XP at Outperform With $20 Price Target MT
25-01-24 XP Shares Rise After Upgrade From UBS MT
25-01-24 UBS Upgrades XP to Buy From Neutral, Cuts Price Target to $16 From $19 MT
24-12-10 BofA Securities Downgrades XP to Neutral From Buy, Price Target is $16 MT
24-11-25 UBS Cuts Price Target on XP to $19 From $21, Maintains Neutral Rating MT
24-07-11 UBS Downgrades XP to Neutral From Buy, Cuts Price Target to $21 From $30 MT
24-07-05 Bradesco BBI Downgrades XP to Neutral From Outperform, Cuts Price Target to $19 From $31 MT
24-06-05 Citigroup Adjusts Price Target on XP to $27 From $29, Maintains Buy Rating MT
24-04-30 XP Shares Decline After Goldman Sachs Downgrade MT
24-04-30 Goldman Sachs Downgrades XP to Neutral From Buy, Cuts Price Target to $23 From $30 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-13.55%
+22.08%
+19.52%
+23.26%
+26.36%
-11.29%
+46.84%
+46.74%
+46.52%
+23.65%
Average +23.01%
Weighted average by Cap. +22.74%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
151.47BRL
Average target price
132.75BRL
Spread / Average Target
-12.36%
High Price Target
189.57BRL
Spread / Highest target
+25.16%
Low Price Target
103.67BRL
Spread / Lowest Target
-31.56%

Analyst Consensus Detail

Analyst consensus - XP Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - XP Inc.
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - XP Inc.